In addition, prognostic analyses indicated that only HK2 expression was positively correlated with poor prognosis (Figs 5C and S2A–D) and malignancy (Fig. 5D) in glioma patients in the GEPIA and UCSC Xena databases, respectively. The gene discussed is HK2; the disease is glioma.